Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lewis T. Local Means of Producing the Triple Response in the Blood Vessels of Human Skin and Their Responses. London: Shaw & Son, 1927:46–64.
Steinhoff M, Stander S, Seeliger S, et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003;139:1479–1488.
Bayliss W. On the origin from the spinal cord of vasodilator fibers of the hind limb, and on the nature of these fibers. J Physiol 1901;26:173–209.
Bruce AN. Vasodilator axon reflexes. Q J Exp Physiol 1913;6:339–354.
Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick‘s Dermatology in General Medicine, 6th ed. New York: McGraw-Hill. 2003.
Metze D, Luger T. Nervous system in the skin: new basic science in dermatology. In: Freinkel RK, Woodley DT, eds. The Biology of the Skin. New York: Parthenon, 2001:153–165.
Stander S, Steinhoff M, Schmelz M, et al. Neuro-physiology of pruritus. Arch Dermatol 2003; 139:1463–1470.
Sternini C. Organization of the peripheral nervous system: autonomic and sensory ganglia. J Invest Dermatol Symp Proc 1997;2:1–7.
Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000;21:457–487.
Scholzen T, Armstrong CA, Bunnett NW, et al. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81.
Lotti T, Hautmann G, Panconesi E, Neuropeptides in skin. J Am Acad Dermatol 1995;33:482–96.
Zegarska B, Leinska A, Tyrakowski T. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep 2006;58:13–21.
Eedy DJ, Shaw C, Johnston CF, Buchanan KD. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 1994;19:761–763.
Ansel JC, Armstrong CA, Song I, et al. Interactions of the skin and nervous system. J Invest Dermatol Symp Proc 1997;2:23–26.
Scholzen TE, Steinhoff M, Bonaccorshi P et al. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis.J Immunol 2001;166:1285–1291.
Misery L. The neuro-immuno-cutaneous system and ultraviolet radiation. Photodermatol Photoimmunol Photomed 2000;16:78–81.
Brain SD, Cox HM. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 2006;147:S202–S211.
Torii H, Yan Z, Hosoi J, Granstein RD. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J Invest Dermatol 1997;109:586–91.
Scholzen TE, Brzoska T, Kalden DH, et al. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J Invest Dermatol Symp Proc 1999;4:55–60.
Koizumi H, Tanaka H, Fukaya T, Ohkawara A. Substance P induces intracellular calcium increase and translocation of protein kinase C in epidermis. Br J Dermatol 1992;127;595–9.
Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation:a minireview. Eur J Dermatol 1998;8:299–306.
Seiffert K, Granstein RD. Neuropeptides and neu-roendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002;97–103.
Luger TA. Neuromediators–a crucial component of the skin immune system. J Dermatol Sci 2002;30:87–93.
Kodali S, Ding W, Huang J, et al. Vasoactive intestinal peptide modulates langerhans cell immune function. J Immunol 2004;173:6082–6088.
Steinhoff M, McGregor GP, Radleff-Schlimme A, et al. Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 1999;80:49–55.
Kodali S, Friedman I, Ding W, et al. Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function. Eur J Immunol 2003;33:3070–3079.
Amara SG, Jonas V, Rosenfeld MG, et al. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982;298:240–4.
Hosoi J, Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing calci-tonin gene-related peptide. Nature 1993;363:159–63.
Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit mac-rophage function. J Immunol 1989;143:45–49.
Fox FE, Kubin M, Cassin M, et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononu-clear cells: effects on B7, interleukin 10, and inter-leukin 12. J Invest Dermatol 1997;108:43–8.
Carucci JA, Ignatius R, Wei Y, et al. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven t cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol 2000;164:3494–3499.
Gillardon F, Moll I, Michel S, et al. Calcitonin gene-related peptide and nitric oxide are involved in ultraviolet radiation-induced immunosuppression. Eur J Pharmacol 1995;293:395–400.
Niizeki H, Alard P, Streilein JW. Calcitonin gene-related peptide is necessary for ultraviolet B-impaired binduction of contact hypersensitivity. J Immunol 1997;159:5183–5186.
Garssen J, Buckley TL, Van Loveren H. A role for neuropeptides in UVB-induced systemic immuno-suppression. Photochem Photobiol 1998;68:205–10.
Bohm, M, Luger TA, Tobin DJ, Garcia-Borron J. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 2006;126:1966–1975.
Brazzini B, Ghersetich I, Hercogova J, Lotti T. The neuro-immuno-cutaneous endocrine network:relationship between mind and skin. Dermatol Ther 2003;16:123–131.
Catania A, Airaghi L, Garofalo L, et al. The neuropeptide alpha-MSH in HIV infection and other disorders in humans. Ann NY Acad Sci 1998;840:848–56.
Grabbe S, Bhardwaj RS, Mahnke K, et al. Alpha-melanocyte stimulating hormone induces hap-ten-specific tolerance in mice. J Immunol 1996;156:473–478.
Catania A, Cutuli M, Garofalo L, et al. The neu-ropeptide α-MSH in host defense. Ann NY Acad Sci 2000;917:227–231.
Ceriani G, Diaz J, Murphree S, et al. The neu-ropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1994;1:28–32.
Chiao H, Foster S, Thomas R, et al. Alpha-melanocyte stimulation hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996;97:2038–2044.
Schallreuter KU, Lemke KR, Pittelkow MR, et al. Catecholamines in human keratinocyte differentiation. J Invest Dermatol 1995;104:953–957.
Seiffert K, Hosoi J, Torri, H, et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002;168:6128:6135.
Maestroni GJM. Dendritic cells migration controlled by α1b-adrenergic receptors. J Immunol 2000;165:6743–6747.
Lambert RW, Campton K, Ding W, et al. Langerhans cell expression of neuropeptide Y and peptide YY. Neuropeptides 2002;36:246–251.
Holzer AM, Granstein RD. Role of extracellular adenosine triphosphate in human skin. J Cutan Med Surg 2004;90–96.
Cook SP, McCleskey EW. Cell damage excites nociceptors through release of cytosolic ATP. Pain 2002;95:41–47.
Seiffert K, Ding W, Wagner JA, Granstein RD. AT P ΥS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 2006;126:1017–1027.
Granstein RD, Ding W, Huang J et al. Augmentation of cutaneous immune responses by ATP gamma S:purinergic agonists define a novel class of immuno-logic adjuvants. J Immunol 2005;174:7725–31.
Roosterman D, Goerge T, Schneider SW, et al. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006;86:1309–1379.
Borici-mazi, Kouridakis S, Kontou-Fili K. Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene. Allergy 1999;54:46–56.
Akiyama M, Watanabe Y, Nishikawa T. Immunohistochemical characterization of human cutaneous mast cells in urticaria pigmentosa (cutaneous mastocytosis). Acta Pathol Jpn 1991;41:344–9.
Artuc M, Bohm M, Grutzhau A, et al. Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases and evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol 2006;126:1976–81.
Twycross R, Greaves MW, Handwerker H, et al. Itch: more than scratching the surface. Q J Med 2003;96:7–26
Sonkoly E, Muller A, Lauerma A. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411–7.
Raap U, Kapp A. Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunology 2005;5:419–424.
Sugiura H, Omoto M, Hirota Y, et al. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997;289:125–131.
Pincelli C, Sevignani C, Manfredini R, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinoc-ytes. J Invest Dermatol 1994;103:13–18.
Staniek V, Liebich C, Vocks E, et al. Modulation of cutaneous Sp receptors in atopic dermatitis after U VA irradiation. Acta Derm Venereol 1998‘78:92–94.
Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibers. Acta Derm Venereol 2004;84:111–115.
Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995;6:462–7.
Fantini F, Pincelli C, Romualdi P, et al. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992;3:127–8.
Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003;295:2–7.
Anand A, Springall DR, Blank MA, et al. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991;124:547–549.
Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Br J Dermatol 2006;154:876–882.
Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunocytochemi-cal and radioimmunoassay study. J Invest Dermatol 1991;96:434–438.
Chan J, Smoller BR, Raychauduri SP, et al. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res1997;289:611–616.
Glinska W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994;131:260–4.
Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 1994;131:160–5.
Falaballa R, Barona MI, Echeverri IC, Alzate A. Substance P may play a part during depigmenta-tion in vitiligo. A pilot study. J Eur Acad Dermatol Venereol 2003;17:355–6.
Lazarova R, Hristakieva E, Lazarov N, Shani J. Vitiligo-related neuropeptides in nerve fibers of the skin. Arch Physiol Biochem 2000;108:262–267.
Liu PY, Bondesson L, Lontz W, Johansson O. The occurrence of cutaneous nerve endings and neu-ropeptides in vitiligo vulgaris: a case-control study. Arch Dermatol Res 1996;288:67–675.
Gulec AT, Tanriverdi N, Duru C et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004;43:352–356.
Kim HS, Cho DH, Kim HJ, et al. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata. Exp Dermatol 2006;15:515–22.
Gutwald J, Goebeler M, Sorg C. Neuropeptides enhance irritant and allergic contact dermatitis. J Invest Dermatol 1991;96:695–698.
Asahina A, Hosoi J, Beissert S, et al. Inhibition of the induction of delayed-type and contact hypersensitiv-ity by calcitonin gene-related peptide. J Immunol 1995;154:3056.
Goebeler M, Henseleit U, Roth J, Sorg C. Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis. Arch Dermatol Res 1994;286:341–346.
Torii H, Hosoi J, Beissert S, et al. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J Leukoc Biol 1997;61:216–223.
Hart PH, Townley SL, Grimbaldeston MA, et al. Mast cells, neuropeptides, histamine, and prostaglan-dins in UV-induced systemic immunosuppression. Methods 2002;28:79–89.
Townley SL, Grimbaldeston MA et al. Nerve growth factor, neuropeptides and mast cells in ultraviolet-B-induced systemic suppression of contact hyper-sensitivity responses in mice. J Invest Dermatol 2002;396–401.
Noonan FP, De Fabo ED. Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol Today 1992;13:250–254.
Khalil Z, Townley SL, Grimbaldeston MA, et al. Cis-urocanic acid stimulates neuropeptide release from peripheral sensory nerves. J Invest Dermatol 2001;117:886–891.
Haegerstrand A, Dalsgaard CJ, Jonzon B, et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990;87:3299–303.
Olerud JE, Usui ML, Seckin D et al. Neutral endopepti-dase expression and distribution in human skin and wounds. J Invest Dermatol 1999;112:873–81.
Antezana M, Sullivan S, Usui M, et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 2002;119:1400–4.
Peters EM, Ericson ME, Hosoi J, et al. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 2006;126:1937–1947.
Tobin DJ, Kauser S. Hair melanocytes as neuro-endocrine sensors—pigments of our imagination. Mol Cell Endocrinol 2005;243:1–11.
Kauser S, Thody AJ, Schallreuter KU, et al. A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes. Endocrinology 2005;146:532–43.
Lavker RM, Kligman AM. Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1998;90:325–30.
Toyoda M, Hara M, Bhawan J. Epidermal inner- vation correlates with severity of photodamage: a quantitative ultrastructural study. Exp Dermatol 1996;5:260–6.
Toyoda M, Nakamura M, Nakada K, et al. Characteristic alterations of cutaneous neurogenic factors in photaged skin. Br J Dermatol 2005;153:13–22.
Eves PC, MacNeil S, Haycock JW. α-Melanocyte stimulating hormone, inflammation and human melanoma. Peptides 2006;27:444–452.
Kim MH, Cho D, Kim HJ, et al. Investigation of the corticotropin-releasing hormone-proopiomelano-cortin axis in various skin tumors. Br J Dermatol 2006;155:910–915.
Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117: 294–300.
Bastiaens MT, ter Huurne JA, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001;68:884–94.
Kanetsky PA, Rebbeck TR, Hummer AJ, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006;66:9330–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Lee, E., Granstein, R.D. (2008). Neuroimmunology. In: Gaspari, A.A., Tyring, S.K. (eds) Clinical and Basic Immunodermatology. Springer, London. https://doi.org/10.1007/978-1-84800-165-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-84800-165-7_3
Publisher Name: Springer, London
Print ISBN: 978-1-84800-164-0
Online ISBN: 978-1-84800-165-7
eBook Packages: MedicineMedicine (R0)